Effective treatment option (not only) for advanced renal cell carcinoma

被引：0

|

作者：

不详

机构：

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷 / 03期

关键词：

TUMOR-CELLS; CABOZANTINIB; INHIBITOR;

D O I：

10.1159/000537951

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：112 / 113

页数：2

相关论文

共 50 条

[1] CYTOREDUCTIVE TREATMENT IN METASTATIC RENAL CELL CARCINOMA: IS NEPHRECTOMY THE ONLY OPTION?
Bolgeri, Marco
Emara, Amr
Barber, Neil J.
JOURNAL OF ENDOUROLOGY, 2012, 26 : A299 - A300
[2] Sunitinib in advanced renal cell carcinoma: New treatment option
Ronald M. Bukowski
Current Oncology Reports, 2007, 9 (2) : 87 - 88
[3] Advanced Renal Cell Carcinoma Cabozantinib plus Nivolumab becomes Treatment Option of the Future
Schmale, Ine
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (12)
[4] Treatment of advanced renal cell carcinoma
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2007, 49 (1276): : 103 - 104
[5] Tivozanib: a new treatment option for renal cell carcinoma
Saes, L.
Eskens, F. A. L. M.
DRUGS OF TODAY, 2017, 53 (11) : 609 - 618
[6] A new treatment option for metastatic renal cell carcinoma
不详
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (05) : 538 - 538
[7] Advanced Renal Cell Carcinoma Cabozantinib is a recommended Treatment Option for First-line Therapy
Schmale, Ine
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (03) : 150 - 151
[8] Bevacizumab as a treatment option in advanced renal cell carcinoma: An analysis and interpretation of clinical trial data
McDermott, David F.
George, Daniel J.
CANCER TREATMENT REVIEWS, 2010, 36 (03) : 216 - 223
[9] Lenvatinib plus Everolimus in advanced Renal Cell Carcinoma New effective Second Line Therapy-Option
Gunther, Jeannine
ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (04) : 229 - 229
[10] Imiquimod: An effective treatment option for patients with basal cell carcinoma
Karve, Sudeep
Yentzer, Brad A.
Balkrishnan, Rajesh
Feldman, Steven
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB142 - AB142

← 1 2 3 4 5 →